Hashiona is a healthcare startup founded in 2020 and headquartered in Poland. The company's slogan emphasizes its focus on improving the quality of life for individuals with Hashimoto's disease by reducing harmful antibodies in the blood. Hashiona's all-in-one platform offers personalized nutrition plans, a symptom tracking system, and extensive knowledge of the disease, specifically targeting women dealing with Hashimoto's.
With a recent PLN1.15M Seed Round investment on 02 September 2022, Hashiona has demonstrated its potential to attract funding and support. While the specific investors for this round are not disclosed, the investment indicates a growing interest in the unique value proposition Hashiona provides within the healthcare industry.
The company's commitment to leveraging data and creating an automated, highly personalized program reflects a forward-thinking approach to addressing health challenges. By focusing on data-driven solutions, Hashiona is poised to make a meaningful impact on the quality of life for individuals with Hashimoto's disease.